135 related articles for article (PubMed ID: 2442539)
1. Rapid eye movement sleep and the associated cardiovascular changes during and after continuous 10-day infusion of clonidine in normotensive rats: comparison with lofexidine and S3341.
Lewis SJ; Jarrott B; Doyle AE
J Cardiovasc Pharmacol; 1987 Jun; 9(6):711-8. PubMed ID: 2442539
[TBL] [Abstract][Full Text] [Related]
2. Rapid eye movement (REM)-sleep during and after continuous infusion of the oxazoline derivate S3341: a comparison with clonidine.
Lewis SJ; Jarrott B; Doyle AE
J Hypertens Suppl; 1984 Dec; 2(3):S45-7. PubMed ID: 6599698
[TBL] [Abstract][Full Text] [Related]
3. Effects of continuous infusions (10 days) and cessation of infusions of clonidine and rilmenidine (S 3341) on cardiovascular and behavioral parameters of spontaneously hypertensive rats.
Jarrott B; Lewis SJ; Doyle AE; Louis WJ
Am J Cardiol; 1988 Feb; 61(7):39D-44D. PubMed ID: 2894156
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular effects of rilmenidine, a new alpha 2-adrenoceptor agonist, and clonidine in conscious spontaneously hypertensive rats.
Sannajust F; Julien C; Barrès C; Cerutti C; Koenig-Bérard E; Sassard J
Clin Exp Pharmacol Physiol; 1989 Nov; 16(11):837-48. PubMed ID: 2575474
[TBL] [Abstract][Full Text] [Related]
5. Influence of the alpha-2 agonist oxaminozoline (S3341) on firing rate of central noradrenergic and serotonergic neurons in the rat. Comparison with clonidine.
Dresse A; Scuvée-Moreau J
Arch Int Physiol Biochim; 1986 Jun; 94(2):99-106. PubMed ID: 2430542
[TBL] [Abstract][Full Text] [Related]
6. Preliminary clinical pharmacological studies of S3341, a new hypotensive agent, and comparison with clonidine in normal males.
Weerasuriya K; Shaw E; Turner P
Eur J Clin Pharmacol; 1984; 27(3):281-6. PubMed ID: 6150856
[TBL] [Abstract][Full Text] [Related]
7. Interference of enantiomers of lofexidine with alpha-adrenoceptors.
Wilffert B; Mathy MJ; Batink HD; de Jonge A; Thoolen MJ; Prop G; Graf E; Timmermans PB; van Zwieten PA
Arch Int Pharmacodyn Ther; 1985 Jan; 273(1):18-32. PubMed ID: 2988468
[TBL] [Abstract][Full Text] [Related]
8. Clonidine and rilmenidine suppress hypotension-induced Fos expression in the lower brainstem of the conscious rabbit.
Li YW; Dampney RA
Neuroscience; 1995 May; 66(2):391-402. PubMed ID: 7477880
[TBL] [Abstract][Full Text] [Related]
9. Influence of anaesthesia on the cardiovascular effects of rilmenidine and clonidine in spontaneously hypertensive rats.
Sannajust F; Cerutti C; Koenig-Bérard E; Sassard J
Br J Pharmacol; 1992 Mar; 105(3):542-8. PubMed ID: 1352719
[TBL] [Abstract][Full Text] [Related]
10. Ethanol selectively counteracts hypotension evoked by central I(1)-imidazoline but not alpha2-adrenergic receptor activation in spontaneously hypertensive rats.
El-Mas MM; Abdel-Rahman AA
J Cardiovasc Pharmacol; 1998 Sep; 32(3):382-9. PubMed ID: 9733351
[TBL] [Abstract][Full Text] [Related]
11. Role of imidazoline receptors in the cardiovascular actions of moxonidine, rilmenidine and clonidine in conscious rabbits.
Chan CK; Sannajust F; Head GA
J Pharmacol Exp Ther; 1996 Feb; 276(2):411-20. PubMed ID: 8632304
[TBL] [Abstract][Full Text] [Related]
12. Importance of central noradrenergic and serotonergic pathways in the cardiovascular actions of rilmenidine and clonidine.
Head GA; Burke S
J Cardiovasc Pharmacol; 1991 Dec; 18(6):819-26. PubMed ID: 1725893
[TBL] [Abstract][Full Text] [Related]
13. Double-blind comparison of the hypotensive, sedative and salivary flow effects of lofexidine and clonidine in normal subjects.
Dollery CT; Reid JL
Arzneimittelforschung; 1982; 32(8a):984-7. PubMed ID: 6890374
[TBL] [Abstract][Full Text] [Related]
14. Effects of clonidine infusion and withdrawal on blood pressure and behaviour in the rat. A preliminary study.
Conway EL; Jarrott B
Clin Exp Hypertens A; 1982; 4(8):1323-34. PubMed ID: 6889477
[TBL] [Abstract][Full Text] [Related]
15. Cardiac vagal effects of rilmenidine in the dog: comparison with clonidine.
Boucher M; Dubar M; Chapuy E; Chassaing C
J Auton Pharmacol; 1997 Apr; 17(2):87-90. PubMed ID: 9234078
[TBL] [Abstract][Full Text] [Related]
16. The involvement of central alpha adrenoceptors in the antihypertensive actions of methyldopa and clonidine in the rat.
Jarrott B; Lewis S; Conway EL; Summers R; Louis WJ
Clin Exp Hypertens A; 1984; 6(1-2):387-400. PubMed ID: 6321066
[TBL] [Abstract][Full Text] [Related]
17. Pharmacology of the alpha 2-adrenoceptor agonist rilmenidine.
Van Zwieten PA
Am J Cardiol; 1988 Feb; 61(7):6D-14D. PubMed ID: 2894160
[TBL] [Abstract][Full Text] [Related]
18. Animal experiments on the cardiovascular effects of lofexidine.
Graf E; Doppelfeld IS; Prop G
Arzneimittelforschung; 1982; 32(8a):941-55. PubMed ID: 6890368
[TBL] [Abstract][Full Text] [Related]
19. Assessment of safety, cardiovascular and subjective effects after intravenous cocaine and lofexidine.
De La Garza R; Galloway GP; Newton TF; Mendelson J; Haile CN; Dib E; Hawkins RY; Chen CY; Mahoney JJ; Mojsiak J; Lao G; Anderson A; Kahn R
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Apr; 50():44-52. PubMed ID: 24316175
[TBL] [Abstract][Full Text] [Related]
20. Effects of rilmenidine and clonidine on the electroencephalogram, saccadic eye movements, and psychomotor function.
Harron DW; Hasson B; Regan M; McClelland RJ; King DJ
J Cardiovasc Pharmacol; 1995; 26 Suppl 2():S48-54. PubMed ID: 8642806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
